Kathrin Kläsener

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Heart Rate Variability

Top Venues

The EMBO journal

Proceedings of the National Academy of Sciences of the United States of America

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Camponeschi, Kathrin Kläsener, Timothy Sundell, Christina Lundqvist, Paul T Manna, Negar Ayoubzadeh, Martina Sundqvist, Katrin Thorarinsdottir, Mariele Gatto, Marcella Visentini, Karin Önnheim, Alaitz Aranburu, Huamei Forsman, Olov Ekwall, Linda Fogelstrand, Inger Gjertsson, Michael Reth, Inga-Lill Mårtensson
Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. The Journal of experimental medicine 219 (9) (2022)
Kathrin Kläsener, Julia Jellusova, Geoffroy Andrieux, Ulrich Salzer, Chiara Böhler, Sebastian N Steiner, Jonas B Albinus, Marco Cavallari, Beatrix Süß, Reinhard E Voll, Melanie Boerries, Bernd Wollscheid, Michael Reth
CD20 as a gatekeeper of the resting state of human B cells. Proceedings of the National Academy of Sciences of the United States of America 118 (7) (2021)
Jennifer J Schwarz, Lorenz Grundmann, Thomas Kokot, Kathrin Kläsener, Sandra Fotteler, David Medgyesi, Maja Köhn, Michael Reth, Bettina Warscheid
Quantitative proteomics identifies PTP1B as modulator of B cell antigen receptor signaling. Life science alliance 4 (11) (2021)
Hannah P Savage, Kathrin Kläsener, Fauna L Smith, Zheng Luo, Michael Reth, Nicole Baumgarth
TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections. eLife 8 (2019)
Xiaocui He, Kathrin Kläsener, Joseena M Iype, Martin Becker, Palash C Maity, Marco Cavallari, Peter J Nielsen, Jianying Yang, Michael Reth
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells. The EMBO journal 37 (11) (2018)